What is NDC 55111-130?

55111-130 is the product NDC for Ranitidine Hydrochloride, Ranitidine hydrochloride 300 mg/1 capsule, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranitidine Hydrochloride?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranitidine Hydrochloride NDC 55111-130

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55111-130-01	5511101300155111013001	100 CAPSULE in 1 BOTTLE (55111-130-01)Marketed from Apr 1, 2001
55111-130-30	5511101303055111013030	30 CAPSULE in 1 BOTTLE (55111-130-30)Marketed from Apr 1, 2001

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranitidine Hydrochloride
Generic name (nonproprietary): ranitidine hydrochloride
Active ingredients: Ranitidine hydrochloride — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Dr. Reddy's Laboratories LimitedNDC labeler code 55111
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075742
Marketing start: Apr 1, 2001
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55111-130_9741e6f4-a2dc-7543-1138-da97eafe11bdSPL ID 9741e6f4-a2dc-7543-1138-da97eafe11bdSPL set ID 7bf94bf7-fa11-70be-9f65-fe26a3db5a63RxCUI 198190, 198192UNII BK76465IHM
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111013001 followed by a unit qualifier and the quantity

Package 55111-0130-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 21, 2018.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ranitidine is indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3.The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis). 4. Short-term treatment of active, benign gastric ulcer. Most patients heal within 6 weeks and the usefulness o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-130

What is NDC 55111-130?: 55111-130 is the product NDC for Ranitidine Hydrochloride, Ranitidine hydrochloride 300 mg/1 capsule, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranitidine Hydrochloride.
What is the active ingredient?: Ranitidine hydrochloride.
Who is the labeler?: Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranitidine Hydrochloride?: 1 other product NDC are listed under this name. See all Ranitidine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranitidine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranitidine Hydrochloride	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Dr. Reddy's Laboratories Limited	55111-129	55111-0129-0555111-0129-60

Other NDCs under ANDA 075742

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075742
Product	Strength	Form · route	Labeler	Product NDC
Ranitidine Hydrochloride	Ranitidine hydrochloride 150 mg/1	CapsuleOral	Dr. Reddy's Laboratories Limited	55111-129